Companies Cryptocurrencies
Tricida Inc
Tricida Inc
Exchange: NasdaqGS
IPO Date: 28/06/2018
CEO: Dr. Gerrit Klaerner
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • TCDA
  • 9.58
  • 530970528
    market cap
  • -0.3699999
If you bought

shares of Tricida Inc (TCDA) on
You would have made
Old Price $12 Current Price $12

Tricida, Inc. is a pharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 104 full-time employees. The firm’s lead program, TRC101 is a treatment for chronic kidney disease (CKD). The firm is engaged in developing a non-absorbed drug to enable safety and efficacy for chronic treatment of CKD patients. The TRC101 drug acts in the gastrointestinal tract and clears the human body through the digestive system, by preventing degradation and systemic uptake.

Address: 7000 Shoreline Ct Ste 201 South San Francisco CALIFORNIA 94080

Stay updated.